Each year, bladder cancer is responsible for thousands of deaths. Even though there are a number of treatments available, this form of the disease is particularly difficult to treat.
Steve Baker is a true survivor. For the better part of the last 25 years, he has been battling several types of malignancy. In the beginning, it was skin cancer, then it attacked his kidneys, and more recently he has been affected by cancer of the bladder. Serenely, Steve admits that there might have been more, but that he stopped looking a while back.
Many would have given up, but Steve never faltered. After so much bad news, his luck finally changed for the better. He did not know it at the time, but the moment he entered a clinical trial for a low-grade invasive cancer of the urinary system would be one he would remember for the rest of his life.
This was an innovative procedure, whereafter resecting the bladder tumor, this new drug was simply inserted through a saline solution directly inside the bladder. The medication was Gemcitabine.
The reason why this type of cancer is so hard to treat lays with the fact that is has a high recurrence chance. Abnormal cells easily float to other parts of the organ and the ordeal begins again. This time was not the case. Gemcitabine reduces the risk by 34% and is designed to be an affordable solution that anyone can opt for.
Dr. Svatek, Urological Oncologist at UT Health San Antonio and head of the projects said: “This is a huge difference in recurrence rate and demonstrated that gemcitabine is a safe and well-tolerated drug. We expect this study to change the standard of care”.
There are many others in the same situation as Steve, and this drug will hopefully change their lives for the better, too.